New antibody tested to restore skin color in vitiligo
NCT ID NCT04338581
Summary
This study tested an investigational drug called AMG 714 to see if it could help restore skin color (repigmentation) in adults with vitiligo. The trial involved 60 participants and compared the drug against a placebo over 24 weeks. Researchers also looked at whether adding light therapy (nbUVB) after the drug treatment improved results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Northwell Health
Lake Success, New York, 11042, United States
-
Tufts Medical Center: Department of Dermatology
Boston, Massachusetts, 02111, United States
-
University of California Davis Health System: Department of Dermatology
Sacramento, California, 95816, United States
-
University of California, Irvine: Department of Dermatology
Irvine, California, 92697, United States
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01605, United States
-
Yale University School of Medicine: Department of Dermatology
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.